A Aralex Aachen research explorer

August 21, 2017 article

Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study

Journal of Clinical Oncology

DOI: 10.1200/jco.2017.73.4293 OpenAlex

Authors 0

Author list not loaded yet.

Cited by 1 stored of 91

INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
2023 British Journal of Cancer article Medicine Ovarian cancer diagnosis and treatment Open access

26

citations

1 result

References 0